Payments to Acquire Property, Plant, and Equipment of Cellectar Biosciences, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Cellectar Biosciences, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Cellectar Biosciences, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $21,633.
  • Cellectar Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $5,880, a 94% decline from 2024.
  • Cellectar Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $104,195, a 88% decline from 2023.
  • Cellectar Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $864,038, a 282% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Cellectar Biosciences, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,880 -$98,315 -94% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $104,195 -$759,843 -88% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $864,038 +$638,067 +282% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $225,971 +$84,610 +60% 01 Jan 2022 31 Dec 2022 10-K/A 29 Oct 2024 2023 FY
2021 $141,361 +$79,008 +127% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $62,353 +$37,811 +154% 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
2019 $24,542 -$360,451 -94% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
2018 $384,993 +$38,290 +11% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2020 2019 FY
2017 $346,703 +$274,452 +380% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2019 2018 FY
2016 $72,251 +$13,781 +24% 01 Jan 2016 31 Dec 2016 10-K 21 Mar 2018 2017 FY
2015 $58,470 +$28,901 +98% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $29,569 -$118,243 -80% 01 Jan 2014 31 Dec 2014 10-K/A 20 Oct 2016 2015 FY
2013 $147,812 +$50,121 +51% 01 Jan 2013 31 Dec 2013 10-K 20 May 2015 2014 FY
2012 $97,691 -$20,720 -17% 01 Jan 2012 31 Dec 2012 10-K 19 Mar 2014 2013 FY
2011 $118,411 +$116,759 +7068% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY
2010 $1,652 01 Jan 2010 31 Dec 2010 10-K 09 Mar 2012 2011 FY

Cellectar Biosciences, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $21,633 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2022 $30,070 01 Jan 2022 31 Mar 2022 10-K/A 29 Oct 2024 2023 FY
Q1 2020 $10,553 +$4,311 +69% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $6,242 +$4,817 +338% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $1,425 -$64,876 -98% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $66,301 +$66,301 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q1 2016 $0 -$25,466 -100% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q1 2015 $25,466 +$10,275 +68% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $15,191 -$77,786 -84% 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015 2015 Q1
Q1 2013 $92,977 +$77,828 +514% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $15,149 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.